$1.690
-0.029 (-1.74%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
ANVS 相似图表分析预测
Alphio's ANVS stock price prediction model matches the current Annovis Bio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.72 (+1.82%). The 1-week path is $1.71 (+1.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Annovis Bio Inc 股票吗?
Annovis Bio Inc is not a good buy right now due to significant financial losses and low stock price. The current price is $1.72, with a year-to-date change of -52.88% and a negative net income of -17606382 USD in Q1 2026. The upcoming Phase 3 readout poses a risk, as a negative result could severely impact operations and stock value.
ANVS 股价于 Tuesday 收于 $1.69,此前下跌 -1.74%
Annovis Bio Inc (ANVS) last closed at $1.69, losing -1.74%. These facts feed the 1-day and 1-week ANVS price prediction above.
预测驱动因素
Annovis Bio Inc(ANVS)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 ANVS 最接近的股票,按相似度排序。
ANVS 季节性分析
Historically the probability of a positive September return for ANVS is 0.00%. January offers the highest probability of a positive month at 16.39%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
ANVS 十年价格预测
| 月份 | 最低价 | 平均价 | 最高价 | 潜在回报率 |
|---|---|---|---|---|
| Sep 2026 | $2.05 | $2.37 | $2.49 | +39.95% |
| Oct 2026 | $2.66 | $3.20 | $3.68 | +89.34% |
| Nov 2026 | $2.81 | $3.15 | $3.38 | +86.10% |
| Dec 2026 | $1.94 | $2.37 | $2.39 | +39.95% |
2026 年,Annovis Bio Inc(ANVS)预计区间为 $1.94 至 $3.68。
Annovis Bio Inc 2026 年月度预测
2026 年 Sep,Annovis Bio Inc 预计均价 $2.37,最低 $2.05,最高 $2.49。
2026 年 Oct,Annovis Bio Inc 预计均价 $3.20,最低 $2.66,最高 $3.68。
2026 年 Nov,Annovis Bio Inc 预计均价 $3.15,最低 $2.81,最高 $3.38。
2026 年 Dec,Annovis Bio Inc 预计均价 $2.37,最低 $1.94,最高 $2.39。
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。